Endocrinology and physiology of pseudocyesis

Reproductive Biology and Endocrinology

Volumn 11, Issue 1, 2013, Pages

  Tarín, Juan J ^a   Hermenegildo, Carlos ^a   García Pérez, Miguel A ^a   Cano, Antonio ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Catecholamines; Hypothalamus pituitary ovarian axis; Major depression disorder; Polycystic ovarian syndrome; Sympathetic nervous system

Indexed keywords

CATECHOLAMINE; ESTROGEN; FOLLITROPIN; GONADORELIN; GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; PROLACTIN; STEROID; TESTOSTERONE;

ABDOMINAL DISTENSION; ADRENERGIC SYSTEM; AMENORRHEA; CATECHOLAMINERGIC SYSTEM; DELIVERY; DELUSIONAL DISORDER; DISEASE ASSOCIATION; ENDOCRINOLOGY; ESTROGEN BLOOD LEVEL; ETHNICITY; FETUS MOVEMENT; FOLLITROPIN BLOOD LEVEL; GALACTORRHEA; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERPROLACTINEMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LABOR PAIN; MAJOR DEPRESSION; NEGATIVE FEEDBACK; NEUROENDOCRINE SYSTEM; NONHUMAN; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PHRENIC NERVE; PHYSIOLOGY; PROLACTIN BLOOD LEVEL; PSEUDOPREGNANCY; RACE; REVIEW; TESTOSTERONE BLOOD LEVEL;

DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; POLYCYSTIC OVARY SYNDROME; PSEUDOPREGNANCY;

EID: 84877617597     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-11-39     Document Type: Review

References (102)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, Washinton, DC: APA, 5, in preparation for publication in May 2013, American Psychiatric Association.
2. Pawlowski EJ, Pawlowski MM. Unconscious and abortive aspects of pseudocyesis. Wis Med J 1958, 57:437-540.
3. Ouj U. Pseudocyesis in a rural southeast Nigerian community. J Obstet Gynaecol Res 2009, 35:660-665. 10.1111/j.1447-0756.2008.00997.x, 19751324.
4. Cohen LM. A current perspective of pseudocyesis. Am J Psychiatr 1982, 139:1140-1144.
5. Fried PH, Rakoff AE, Schopbach RR, Kaplan AJ. Pseudocyesis; a psychosomatic study in gynecology. J Am Med Assoc 1951, 145:1329-1335. 10.1001/jama.1951.02920350023005, 14823879.
6. Brenner BN. Pseudocyesis in Blacks. S Afr Med J 1976, 50:1757-1759.
7. Dafallah SE. Pseudocyesis and infertility. Saudi Med J 2004, 25:964-965.
8. Mcquillan J, Greil AL, Shreffler KM, Wonch-Hill PA, Gentzler KC, Hathcoat JD. Does the reason matter? variations in childlessness concerns among U.S. women. J Marriage Fam 2012, 74:1166-1181.
9. O'Grady JP, Rosenthal M. Pseudocyesis: a modern perspective on an old disorder. Obstet Gynecol Surv 1989, 44:500-511. 10.1097/00006254-198907000-00003, 2662076.
10. Brooks JG. Pseudocyesis in a 6-year-old girl: follow-up report at 23. J Am Acad Child Psychiatr 1985, 24:359-362.
11. Milner GL, Hayes GD. Pseudocyesis associated with folie à deux. Br J Psychiatr 1990, 156:438-440.
12. Harland RF, Warner NJ. Delusions of pregnancy in the elderly. Int J Geriatr Psychiatr 1997, 12:115-117.
13. Shutty MS, Leadbetter RA. Case report: recurrent pseudocyesis in a male patient with psychosis, intermittent hyponatremia, and polydipsia. Psychosom Med 1993, 55:146-148.
14. Adityanjee AM. Delusion of pregnancy in males: a case report and literature review. Psychopathology 1995, 28:307-311. 10.1159/000284942, 8838402.
15. Hardwick PJ, Fitzpatrick C. Fear, folie and phantom pregnancy: pseudocyesis in a fifteen-year-old girl. Br J Psychiatr 1981, 139:558-560.
16. Starkman MN, Marshall JC, La Ferla J, Kelch RP. Pseudocyesis: psychologic and neuroendocrine interrelationships. Psychosom Med 1985, 47:46-57.
17. Hernández-Rodríguez I, Moreno MJ, Morano LE, Benavente JL. Systemic lupus erythematosus presenting as pseudocyesis. Br J Rheumatol 1994, 33:400-402. 10.1093/rheumatology/33.4.400, 7908846.
18. Ahuja N, Vasudev K, Lloyd A. Hyperprolactinemia and delusion of pregnancy. Psychopathology 2008, 41:65-68. 10.1159/000110628, 17975330.
19. Posner LB, de Chabert RA, Posner AC. Simulated pregnancy following pseudocyesis. Am J Obstet Gynecol 1962, 83:976-977.
20. Daw E. Pseudocyesis. Br J Clin Pract 1973, 27:181-183.
21. Chambers WR. Brain tumor simulating pregnancy. Am J Obstet Gynecol 1955, 70:212-213.
22. Echániz A, Millán A, del Río Fuentes A, Pedreira JD. Pseudopregnancy and gastric adenocarcinoma. Med Clin (Barc) 1984, 83:307-308.
23. Manzi D, Greenberg B, Maier D, Forouhar F, Malchoff CD. Bronchogenic carcinoma presenting as a pseudopregnancy. Chest 1995, 107:567-569. 10.1378/chest.107.2.567, 7531133.
24. Alfonso CA. Pseudocyesis with concomitant medical illness. Gen Hosp Psychiatr 1990, 12:205-206.
25. Benzick JM. Illusion or hallucination? Cholecystitis presenting as pseudopregnancy in schizophrenia. Psychosomatics 2000, 41:450-452. 10.1176/appi.psy.41.5.450, 11015638.
26. Yeh YW, Kuo SC, Chen CY. Urinary tract infection complicated by urine retention presenting as pseudocyesis in a schizophrenic patient. Gen Hosp Psychiatr 2012, 34:101.e9-101.e10.
27. Flanagan PJ, Harel Z. Pseudocyesis in an adolescent using the long-acting contraceptive Depo-Provera. J Adolesc Health 1999, 25:238-240. 10.1016/S1054-139X(99)00021-X, 10475500.
28. Ahuja N, Moorhead S, Lloyd AJ, Cole AJ. Antipsychotic-induced hyperprolactinemia and delusion of pregnancy. Psychosomatics 2008, 49:163-167. 10.1176/appi.psy.49.2.163, 18354070.
29. Manjunatha N, Saddichha S. Delusion of pregnancy associated with antipsychotic induced metabolic syndrome. World J Biol Psychiatr 2009, 10:669-670.
30. Seeman MV. Antipsychotic-induced amenorrhea. J Ment Health 2011, 20:484-491. 10.3109/09638237.2011.586741, 21942684.
31. Small G. Pseudocyesis: an overview. Can J Psychiatr 1986, 31:452-457.
32. Ayers JW, Seiler JC. Neuroendocrine indices of depression in pseudocyesis. A case report. J Reprod Med 1984, 29:67-70.
33. Devane GW, Vera MI, Buhi WC, Kalra PS. Opioid peptides in pseudocyesis. Obstet Gynecol 1985, 65:183-188.
34. Yen SS, Rebar RW, Quesenberry W. Pituitary function in pseudocyesis. J Clin Endocrinol Metab 1976, 43:132-136. 10.1210/jcem-43-1-132, 947932.
35. Tulandi T, McInnes RA, Mehta A, Tolis G. Pseudocyesis: pituitary function before and after resolution of symptoms. Obstet Gynecol 1982, 59:119-121.
36. McCartney CR, Eagleson CA, Marshall JC. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome. Semin Reprod Med 2002, 20:317-326. 10.1055/s-2002-36706, 12536355.
37. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007, 92:405-413.
38. Massafra C, De Felice C, Agnusdei DP, Gioia D, Bagnoli F. Androgens and osteocalcin during the menstrual cycle. J Clin Endocrinol Metab 1999, 84:971-974. 10.1210/jc.84.3.971, 10084581.
39. Bui HN, Sluss PM, Blincko S, Knol DL, Blankenstein MA, Heijboer AC. Dynamics of serum testosterone during the menstrual cycle evaluated by daily measurements with an ID-LC-MS/MS method and a 2nd generation automated immunoassay. Steroids 2013, 78:96-101. 10.1016/j.steroids.2012.10.010, 23127814.
40. Asukai K, Uemura T, Minaguchi H. Occult hyperprolactinemia in infertile women. Fertil Steril 1993, 60:423-427.
41. Bouilly J, Sonigo C, Auffret J, Gibori G, Binart N. Prolactin signaling mechanisms in ovary. Mol Cell Endocrinol 2012, 356:80-87. 10.1016/j.mce.2011.05.004, 21664429.
42. Maes M, Van Gastel A, Blockx P, Martin M, Cosyns P, Scharpé S, Desnyder R. An augmented escape of androstenedione from suppression by dexamethasone in melancholia: relationships to intact ACTH and cortisol nonsuppression. J Affect Disord 1995, 34:291-300. 10.1016/0165-0327(95)00027-K, 8550955.
43. Maeda K, Kato Y, Ohgo S, Chihara K, Yoshimoto Y, Yamaguchi N, Kuromaru S, Imura H. Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression. J Clin Endocrinol Metab 1975, 40:501-505. 10.1210/jcem-40-3-501, 803976.
44. Extein I, Pottash AL, Gold MS, Silver JM. Thyroid-stimulating hormone response to thyrotropin-releasing hormone in unipolar depression before and after clinical improvement. Psychiatr Res 1982, 6:161-169.
45. Arita H, Kinoshita M, Oshino S, Kitamura T, Otsuki M, Kasayama S, Shimokawa T, Shimomura I, Yoshimine T, Saitoh Y. Biological characteristics of growth hormone-producing pituitary adenomas are different according to responsiveness to thyrotropin-releasing hormone. J Clin Endocrinol Metab 2012, 97:2741-2747. 10.1210/jc.2012-1125, 22569237.
46. Kaltsas T, Pontikides N, Krassas GE, Seferiadis K, Lolis D, Messinis IE. Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome. Hum Reprod 1999, 14:2704-2708. 10.1093/humrep/14.11.2704, 10548605.
47. Chihara K, Kashio Y, Kita T, Okimura Y, Kaji H, Abe H, Fujita T. L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans. J Clin Endocrinol Metab 1986, 62:466-473. 10.1210/jcem-62-3-466, 3080462.
48. Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001, 22:724-763. 10.1210/er.22.6.724, 11739329.
49. Spiliotis BE. Growth hormone insufficiency and its impact on ovarian function. Ann N Y Acad Sci 2003, 997:77-84. 10.1196/annals.1290.009, 14644812.
50. Yen SS, Quigley ME, Reid RL, Ropert JF, Cetel NS. Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretion. Am J Obstet Gynecol 1985, 152:485-493.
51. Hugues JN, Theron-Gerard L, Coussieu C, Pasquier M, Dewailly D, Cedrin-Durnerin I. Assessment of theca cell function prior to controlled ovarian stimulation: the predictive value of serum basal/stimulated steroid levels. Hum Reprod 2010, 25:228-234. 10.1093/humrep/dep378, 19897528.
52. Zarate A, Canales ES, Soria J, Jacobs LS, Daughaday WH, Kastin AJ, Schally AV. Gonadotropin and prolactin secretion in human pseudocyesis: effect of synthetic luteinizing hormone-releasing hormone (LH-RH) and thyrotropin releasing hormone (TRH). Ann Endocrinol (Paris) 1974, 35:445-450.
53. Osotimehin BO, Ladipo OA, Adejuwon CA, Otolorin EO. Pituitary and placental hormone levels in pseudocyesis. Int J Gynaecol Obstet 1981, 19:399-402. 10.1016/0020-7292(81)90024-2, 6120111.
54. Tulandi T, McInnes RA, Lal S. Altered pituitary hormone secretion in patients with pseudocyesis. Fertil Steril 1983, 40:637-641.
55. Forsbach G, Güitron A, Munoz M, Bustos H. Pituitary function in human pseudocyesis. J Endocrinol Invest 1987, 10:39-43.
56. Bray MA, Muneyyirci-Delale O, Kofinas GD, Reyes FI. Circadian, ultradian, and episodic gonadotropin and prolactin secretion in human pseudocyesis. Acta Endocrinol (Copenh) 1991, 124:501-509.
57. Padayachi T, Ashe R, Moodley J, Jialal I. Pituitary function tests in black patients with pseudocyesis. S Afr Med J 1991, 79:24-26.
58. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
59. Burt-Solorzano CM, Beller JP, Abshire MY, Collins JS, McCartney CR, Marshall JC. Neuroendocrine dysfunction in polycystic ovary syndrome. Steroids 2012, 77:332-337. 10.1016/j.steroids.2011.12.007, 3453528, 22172593.
60. Williams KE, Marsh WK, Rasgon NL. Mood disorders and fertility in women: a critical review of the literature and implications for future research. Hum Reprod Update 2007, 13:607-616. 10.1093/humupd/dmm019, 17895237.
61. Legro RS, Schlaff WD, Diamond MP, Coutifaris C, Casson PR, Brzyski RG, Christman GM, Trussell JC, Krawetz SA, Snyder PJ, Ohl D, Carson SA, Steinkampf MP, Carr BR, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Myers ER, Santoro N, Eisenberg E, Zhang M, Zhang H, Reproductive Medicine Network Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab 2010, 95:5305-5313. 10.1210/jc.2010-1123, 2999971, 20826578, Reproductive Medicine Network.
62. Baischer W, Koinig G, Hartmann B, Huber J, Langer G. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology 1995, 20:553-559. 10.1016/0306-4530(94)00081-K, 7675939.
63. Laven JS, Imani B, Eijkemans MJ, Fauser BC. New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 2002, 57:755-767. 10.1097/00006254-200211000-00022, 12447098.
64. Hardoy MC, Serra M, Carta MG, Contu P, Pisu MG, Biggio G. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder. J Clin Psychopharmacol 2006, 26:379-384. 10.1097/01.jcp.0000229483.52955.ec, 16855455.
65. Kaltsas T, Pontikides N, Krassas GE, Seferiadis K, Lolis D, Messinis IE. Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome. Hum Reprod 1998, 13:22-26. 10.1093/humrep/13.1.22, 9512222.
66. Jarrett DB, Kupfer DJ, Miewald JM, Grochocinski VJ, Franz B. Sleep-related growth hormone secretion is persistently suppressed in women with recurrent depression: a preliminary longitudinal analysis. J Psychiatr Res 1994, 28:211-223. 10.1016/0022-3956(94)90007-8, 7932283.
67. Yildiz BO, Azziz R. The adrenal and polycystic ovary syndrome. Rev Endocr Metab Disord 2007, 8:331-342. 10.1007/s11154-007-9054-0, 17932770.
68. Kurita H, Maeshima H, Kida S, Matsuzaka H, Shimano T, Nakano Y, Baba H, Suzuki T, Arai H. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. J Affect Disord 2013, 146(2):205-212. 10.1016/j.jad.2012.09.004, 23102506.
69. Herbert J. Cortisol and depression: three questions for psychiatry. Psychol Med 2012, 8:1-21.
70. Polson DW, Reed MJ, Scanlon MJ, Quiney N, Franks S. Androstenedione concentrations following dexamethasone suppression: correlation with clomiphene responsiveness in women with polycystic ovary syndrome. Gynecol Endocrinol 1988, 2:257-264. 10.3109/09513599809029350, 2976245.
71. Lewandowski KC, Cajdler-Łuba A, Salata I, Bieńkiewicz M, Lewiński A. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS). Endokrynol Pol 2011, 62:120-128.
72. Acar B, Kadanali S. Diminished growth hormone responses to L-dopa in polycystic ovarian disease. Fertil Steril 1993, 60:984-987.
73. Lee EJ, Lee BS, Lee HC, Park KH, Song CH, Huh KB. Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome. Fertil Steril 1993, 60:53-57.
74. McPherson H, Walsh A, Silverstone T. Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression. J Affect Disord 2003, 76:121-125. 10.1016/S0165-0327(02)00077-0, 12943941.
75. Ansseau M, Von Frenckell R, Cerfontaine JL, Papart P, Franck G, Timsit-Berthier M, Geenen V, Legros JJ. Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. Br J Psychiatr 1988, 153:65-71.
76. Pitchot W, Ansseau M, Gonzalez Moreno A, Hansenne M, von Frenckell R. Dopaminergic function in panic disorder: comparison with major and minor depression. Biol Psychiatr 1992, 32:1004-1011.
77. Pitchot W, Hansenne M, Gonzalez Moreno A, Ansseau M. Growth hormone response to apomorphine in panic disorder: comparison with major depression and normal controls. Eur Arch Psychiatr Clin Neurosci 1995, 245:306-308.
78. Barnes RB, Lobo RA. Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation. J Clin Endocrinol Metab 1985, 61:779-782. 10.1210/jcem-61-4-779, 3928677.
79. Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update 2006, 12:351-361. 10.1093/humupd/dml017, 16670102.
80. Martín del Campo AF, Dowson JH, Herbert J, Paykel ES. Diurnal variations in endocrine and psychological responses to 0.2 mg/kg naloxone administration in patients with major depressive disorder and matched controls. J Affect Disord 2000, 57:37-47. 10.1016/S0165-0327(99)00070-1, 10708814.
81. Wortsman J, Hirschowitz JS. Galactorrhea and hyperprolactinemia during treatment of polycystic ovary syndrome. Obstet Gynecol 1980, 55:460-463.
82. Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005, 4:141-194. 10.1016/j.arr.2005.03.003, 15996533.
83. Bao AM, Ji YF, Van Someren EJ, Hofman MA, Liu RY, Zhou JN. Diurnal rhythms of free estradiol and cortisol during the normal menstrual cycle in women with major depression. Horm Behav 2004, 45:93-102. 10.1016/j.yhbeh.2003.09.004, 15019795.
84. Anderson RA, Groome NP, Baird DT. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin Endocrinol (Oxf) 1998, 48:577-584.
85. Fraser IS, Kovacs G. Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004, 18:813-823.
86. Burgers JA, Fong SL, Louwers YV, Valkenburg O, de Jong FH, Fauser BC, Laven JS. Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference?. J Clin Endocrinol Metab 2010, 95:E485-E489. 10.1210/jc.2009-2717, 20843954.
87. Machado-Vieira R, Zarate CA. Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments. Depress Anxiety 2011, 28:267-281. 10.1002/da.20800, 3071576, 21456037.
88. Whelan CI, Stewart DE. Pseudocyesis-a review and report of six cases. Int J Psychiatr Med 1990, 20:97-108.
89. Lambert G, Johansson M, Agren H, Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatr 2000, 57:787-793. 10.1001/archpsyc.57.8.787, 10920468.
90. Esler M, Turbott J, Schwarz R, Leonard P, Bobik A, Skews H, Jackman G. The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatr 1982, 39:295-300. 10.1001/archpsyc.1982.04290030035006, 7065840.
91. Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, Murburg MM, Ashleigh EA, Castillo S, Peskind ER, Pascuali M, Halter JB. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatr 1994, 51:411-422. 10.1001/archpsyc.1994.03950050071008, 8179465.
92. Roy A, Pickar D, Linnoila M, Potter WZ. Plasma norepinephrine level in affective disorders. Relationship to melancholia. Arch Gen Psychiatr 1985, 42:1181-1185. 10.1001/archpsyc.1985.01790350055010, 4074110.
93. Goddard AW, Ball SG, Martinez J, Robinson MJ, Yang CR, Russell JM, Shekhar A. Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety 2010, 27:339-350. 10.1002/da.20642, 19960531.
94. Rasheed N, Alghasham A. Central dopaminergic system and its implications in stress-mediated neurological disorders and gastric ulcers: short review. Adv Pharmacol Sci 2012, 2012:182671. 3449100, 23008702.
95. Hernández I, Parra A, Méndez I, Cabrera V, Cravioto MC, Mercado M, Díaz-Sánchez V, Larrea F. Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome. Arch Med Res 2000, 31:216-222. 10.1016/S0188-4409(00)00059-X, 10880731.
96. Liu X, Herbison AE. Dopamine regulation of gonadotropin-releasing hormone neuron excitability in male and female mice. Endocrinology 2013, 154:340-350. 10.1210/en.2012-1602, 23239814.
97. Han SK, Herbison AE. Norepinephrine suppresses gonadotropin-releasing hormone neuron excitability in the adult mouse. Endocrinology 2008, 149:1129-1135.
98. Jaffe RB, Plosker S, Marshall L, Martin MC. Neuromodulatory regulation of gonadotropin-releasing hormone pulsatile discharge in women. Am J Obstet Gynecol 1990, 163:1727-1731. 10.1016/0002-9378(90)91436-G, 2240130.
99. Villoria A, Azpiroz F, Burri E, Cisternas D, Soldevilla A, Malagelada JR. Abdomino-phrenic dyssynergia in patients with abdominal bloating and distension. Am J Gastroenterol 2011, 106:815-819. 10.1038/ajg.2010.408, 21540894.
100. Ewing MR, Millar JH. Hysterical abdominal proptosis; records of a case. Br Med J 1955, 2:1124-1125. 10.1136/bmj.2.4948.1124, 1981352, 13260679.
101. Lerner MA. Hysterical abdominal proptosis. Am J Roentgenol Radium Ther Nucl Med 1974, 122:275-277. 10.2214/ajr.122.2.275, 4278655.
102. Alvarez WC. Hysterical type of nongaseous abdominal bloating. Arch Intern Med (Chic) 1949, 84:217-245.